Sponsored Content: Preventing COVID-19 with Long Duration Monoclonal Antibody Therapy: Trial Data, Viral Variants, and More, Part 2
In this episode, Dr. Neil Skolnik and Dr. Myron J. Levine discuss the use of long-acting monoclonal antibodies for COVID-19 pre-exposure prophylaxis. They explore the challenges and opportunities primary care clinicians and specialists face identifying appropriate patients to receive this treatment, with emphasis on patients who are immunocompromised and may not respond to vaccination.
This episode is part two of a three part series that examines the use of tixagevimab and cilgavimab for pre-exposure prophylaxis of COVID-19.
This podcast episode is sponsored by AstraZeneca.
This activity does not offer CME/CE credit
Faculty:
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Abington Jefferson Health
Philadelphia, PA
Myron J. Levin, MD
Associate Director, Pediatric HIV Clinic
Professor, Pediatrics-Infectious Diseases
University of Colorado Anschutz Medical Campus School of Medicine
Aurora, CO
Please visit http://naceonline.com to engage in more live and on demand CME/CE content.
